White v. Genentech-Roche Pharmaceuticals

District Court, E.D. Missouri·Decided August 5, 2020·No. 1:20-cv-00041·Unknown

Opinion

UNITED STATES DISTRICT COURT EASTERN DISTRICT OF MISSOURI SOUTHEASTERN DIVISION MARY L. WHITE, ) Plaintiff, V. Case No. 1:20-CV-41 RLW GENENTECH-ROCHE PHARMACEUTICAL, INC., ) Defendant. MEMORANDUM AND ORDER This matter is before the Court on review of plaintiff Mary White’s amended complaint. After review of the amended complaint and the supplemental amended complaint the Court will dismiss this action pursuant to 28 U.S.C. § 1915(e)(2)(B). Legal Standard Under 28 U.S.C. § 1915(e), the Court is required to dismiss a complaint filed in forma pauperis if it is frivolous, malicious, or fails to state a claim upon which relief can be granted, or seeks monetary relief against a defendant who is immune from such relief. To state a claim for relief, a complaint must plead more than “legal conclusions” and “[t]hreadbare recitals of the elements of a cause of action [that are] supported by mere conclusory statements.” Ashcroft v. Iqbal, 556 U.S. 662, 678 (2009). A plaintiff must demonstrate a plausible claim for relief, which is more than a “mere possibility of misconduct.” Jd. at 679. “A claim has facial plausibility when the plaintiff pleads factual content that allows the court to draw the reasonable inference that the defendant is liable for the misconduct alleged.” Jd. at 678. Determining whether a complaint states a plausible claim for relief is a context-specific task that requires the reviewing court to draw on its judicial experience and common sense. /d. at 679.

When reviewing complaint filed by a self-represented person under 28 U.S.C. § 1915, the Court accepts the well-pled facts as true, White v. Clark, 750 F.2d 721, 722 (8th Cir. 1984), and liberally construes the complaint. Erickson v. Pardus, 551 U.S. 89, 94 (2007); Haines v. Kerner, 404 U.S. 519, 520 (1972). A “liberal construction” means that if the essence of an allegation is discernible, the district court should construe the plaintiff's complaint in a way that permits his or her claim to be considered within the proper legal framework. Solomon v. Petray, 795 F.3d 777, 787 (8th Cir. 2015). However, even self-represented complainants are required to allege facts which, if true, state a claim for relief as a matter of law. Martin v. Aubuchon, 623 F.2d 1282, 1286 (8th Cir. 1980). See also Stone v. Harry, 364 F.3d 912, 914-15 (8th Cir. 2004) (refusing to supply additional facts or to construct a legal theory for the self-represented plaintiff that assumed facts that had not been pleaded). The Amended Complaint On February 20, 2020, self-represented plaintiff Mary L. White filed this civil suit on a Court-provided form against defendant Genentech-Roche Pharmaceutical (“Genentech”).' The Court granted plaintiff's motion to proceed in forma pauperis and reviewed plaintiff's complaint pursuant to 28 U.S.C. § 1915 on March 26, 2020. In the Memorandum and Order issued on that same date, the Court noted that plaintiff had failed to properly allege subject matter jurisdiction in this action and that her complaint was conclusory. The Court ordered plaintiff to file an amended complaint. Plaintiff filed an amended pleading on April 6, 2020, and she filed a supplemental pleading on May 1, 2020.

1 On the same date, plaintiff filed a separate complaint against Dr. Eduardo D. Verzola. See White v. Verzola, 4:20-cv-295-RLW. The two cases share similar facts. The Court dismissed that case for lack of subject matter jurisdiction.

Plaintiff alleges in a conclusory fashion in her amended complaint and supplemental filings that the Bill of Rights should protect her from harm from the side effects of a medication prescribed for her by her doctor and manufactured by defendant. Plaintiff states that she has scarring over her entire body, and that she has suffered “mental abuse.” She claims that her rights under the Eighth Amendment were violated; that harm was done to her physically; that her doctor prescribed the medication that caused her harm; that she will show pictures of this medication; that the medication was unsafe for consumer use, and that the Food and Drug Administration included a warning to stop and treat dangerous side effects; that her rights have been violated under the Consumer Bill of Rights; and that plaintiff's “right to inform” was violated. Plaintiff also contends that under the “Federal Patient Bill of Rights” she has a right to appropriate medical care and humane treatment pursuant to the Eighth Amendment; the right to informed consent under the First Amendment; and the right to information. Plaintiff further alleges that she was harmed by the use of the medication Incivek (telaprevir), Peginterferon alfa, and Ribavirin during the Hep C treatment in the year of 2012 under the care of a doctor and was not aware of the dangers that these medication carried for years. She states that she stumbled across what she believed to have caused her health issues, resulting in this lawsuit. Plaintiff additionally alleges that the under the First Amendment, her rights were violated when the drugs manufactured by defendant failed to provide proper labeling as to side effects. Plaintiff also claims that her Eighth Amendment right was violated because the manufacturer failed to inform the public that the drugs caused serious side effects. As noted above,

she claims that the drugs caused scarring over half her body, mental illness and damaging side effects that occurred later. Plaintiff alleges that in 2012 the manufacturer did not warn the public of the side effects of the danger/or death that could occur as a result of taking the medication.” Specifically, plaintiff alleges that the manufacturer did not properly warn of the purported dangerous side effects and did not warn that the public should not take the medication. Plaintiff seeks monetary damages in this action. Discussion A. Failure to Warn On March 26, 2020, the Court reviewed plaintiffs original complaint pursuant to 28 U.S.C. § 1915. The Court ordered plaintiff at that time that she was required to amend her complaint in order to concisely state how this Court had subject matter jurisdiction over her action. Additionally, plaintiff was told that she needed to concisely set forth her allegations against defendant in her amended complaint. Plaintiff was warned that her amended complaint would replace the original and was instructed that the “Statement of Claim” section of the Court-provided form should be concise and complete. Despite the Court’s instructions, plaintiff submitted the instant amended complaint with less facts than her original complaint. Plaintiff's amended complaint lacks a Statement of Claim section. Rather, it is filled with conclusory allegations and legal conclusions.

Free access — add to your briefcase to read the full text and ask questions with AI

White v. Genentech-Roche Pharmaceuticals, (E.D. Mo. 2020).

White v. Genentech-Roche Pharmaceuticals (White v. Genentech-Roche Pharmaceuticals) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Hanna v. Plumer
380 U.S. 460 (Supreme Court, 1965)
Haines v. Kerner
404 U.S. 519 (Supreme Court, 1972)
Erickson v. Pardus
551 U.S. 89 (Supreme Court, 2007)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
Great Plains Trust Co. v. Union Pacific Railroad
492 F.3d 986 (Eighth Circuit, 2007)
Johnson v. Medtronic, Inc.
365 S.W.3d 226 (Missouri Court of Appeals, 2012)
James Solomon v. Deputy U.S. Marshal Thomas
795 F.3d 777 (Eighth Circuit, 2015)
Manhattan Community Access Corp. v. Halleck
587 U.S. 802 (Supreme Court, 2019)
Martin v. Aubuchon
623 F.2d 1282 (Eighth Circuit, 1980)